The appropriate selection of lung transplant recipients is an important determinant of
outcomes. This consensus document is an update of the recipient selection guidelines …

The selection of appropriate recipients for lung transplantation is an evolving discipline. As
experience with the procedure has developed over the last decades, the identification of …

Cystic fibrosis (CF) is a common lethal genetic disease in the North American population,
affecting 1: 2500 births. There are about 30,000 individuals in the United States with CF, and …

Background. Combined lung and liver transplantation (Lu-LTx) is a therapeutic option for
selected patients with coexisting lung and liver disease. For several reasons, Lu-LTx is …

Patients with end‐stage lung disease complicated by cirrhosis are not expected to survive
lung transplantation alone. Such patients are potential candidates for combined lung‐liver …

Tolerance induction protocols that are successful in patients transplanted with 'tolerance-
prone'organs such as kidneys and livers will most likely not succeed in recipients of …

Arnon R, Annunziato RA, Miloh T, Padilla M, Sogawa H, Batemarco L, Willis A, Suchy F,
Kerkar N. Liver and combined lung and liver transplantation for cystic fibrosis: Analysis of the …

Portopulmonary hypertension (PPHTN) is a known complication of cirrhosis. Moderate-to-
severe PPHTN implies an extremely poor prognosis. It occurs in 5%-10% of patients referred …

Combined liver/thoracic transplantation (cLiThT x) is a complex procedure for end‐
stage/advanced liver and heart (H)/lung (Lu) disease. To avoid futile use of multiple organs …

This article reviews lung transplantation in patients with cystic fibrosis (CF). Lung
transplantation is commonly utilized for patients with end-stage CF. There are several …